Tagged with key opinion leaders

Interview: Miroslav Secerov – VP Sales & Marketing, NATEC Medical, Mauritius

Pharma Interview: Miroslav Secerov – VP Sales & Marketing, NATEC Medical, Mauritius

Pharma Miroslav Secerov, VP Sales & Marketing NATEC, explains the choice of Mauritius for NATEC’s headquarters as well as the unique assets that make Mauritius the ideal business location. He also analyses Mauritius’ recent emphasis on development of the life sciences sector and the public-private relationship required to make that a…

Interview: Yves Bur – Honorary Deputy and Mayor of Lingolsheim, France

Pharma Interview: Yves Bur – Honorary Deputy and Mayor of Lingolsheim, France

Pharma Yves Bur reveals how the motivation behind his political engagement has been to raise awareness around the importance of improving the social security system. Bur also explains why having a real public health policy is another way of combatting the increase in health spending, and how France needs to reach…

Interview: Michel Dutrée – Former Director General of Nefarma, The Netherlands

Pharma Interview: Michel Dutrée – Former Director General of Nefarma, The Netherlands

Pharma Michel Dutree, former director general of the Dutch association for pharmaceutical innovators, gives a detailed overview of the changes happening in the Dutch pharmaceutical industry, and the Netherlands’ role at the European level as the “laboratory of Europe.” It’s been four years since your last interview with PBR; what do…

strategic levels Interview – Umut Gökalp, Managing Director, Sysmex Turkey

strategic levels Umut Gökalp, managing director of Japan’s Sysmex in Turkey – a company specialising in in-vitro diagnostics – evaluates their approach to developing business opportunities in the Turkish medical device sector. He also describes how the company’s new reagent facility in Germany will help bolster it domestically and regionally. Can you tell us…

Other Topics

India

M&A

European Biotech

Cell & Gene Therapy

R&D Section Page